Short answer
Solid Biosciences Inc. (SLDB) filed an 8-K current report with the SEC on June 10, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Shareholders elected Clare Kahn, Adam Stone, and Lynne Sullivan as Class II directors through the 2029 annual meeting.
Solid Biosciences Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Shareholders elected Clare Kahn, Adam Stone, and Lynne Sullivan as Class II directors through the 2029 annual meeting
- PricewaterhouseCoopers LLP ratified as independent auditor for fiscal year 2026 with 86.4 million votes for
- Authorized common shares doubled from 240 million to 480 million, enabling future equity issuance and potential dilution
- Shareholders approved named executive officer compensation with 72.6 million votes for
- Ilan Ganot’s appointment as Class I director ratified through the 2028 annual meeting
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Solid Biosciences Inc. 8-K filings
Get the next SLDB 8-K as it lands
Follow SLDB for push alerts, or ask the research agent what this filing means.